These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Substituted dipiperidine alcohols as potent CCR2 antagonists. Xia M; Hou C; Demong D; Pollack S; Pan M; Brackley J; Singer M; Matheis M; Cavender D; Wachter M Bioorg Med Chem Lett; 2008 Jun; 18(12):3562-4. PubMed ID: 18487045 [TBL] [Abstract][Full Text] [Related]
25. Synthesis of 3-phenylsulfonylmethyl cyclohexylaminobenzamide-derived antagonists of CC chemokine receptor 2 (CCR2). Yang MG; Xiao Z; Shi Q; Cherney RJ; Tebben AJ; De Lucca GV; Santella JB; Mo R; Cvijic ME; Zhao Q; Barrish JC; Carter PH Bioorg Med Chem Lett; 2012 Feb; 22(3):1384-7. PubMed ID: 22225639 [TBL] [Abstract][Full Text] [Related]
26. Design and synthesis of a novel series of histamine H3 receptor antagonists through a scaffold hopping strategy. Gao Z; Hurst WJ; Hall D; Hartung R; Reynolds W; Kang J; Nagorny R; Hendrix JA; George PG Bioorg Med Chem; 2015 Feb; 23(3):429-38. PubMed ID: 25577710 [TBL] [Abstract][Full Text] [Related]
27. Synthesis and structure-activity relationship of 7-azaindole piperidine derivatives as CCR2 antagonists. Xia M; Hou C; DeMong D; Pollack S; Pan M; Singer M; Matheis M; Murray W; Cavender D; Wachter M Bioorg Med Chem Lett; 2008 Dec; 18(24):6468-70. PubMed ID: 18990568 [TBL] [Abstract][Full Text] [Related]
28. Structure of CC chemokine receptor 2 with orthosteric and allosteric antagonists. Zheng Y; Qin L; Zacarías NV; de Vries H; Han GW; Gustavsson M; Dabros M; Zhao C; Cherney RJ; Carter P; Stamos D; Abagyan R; Cherezov V; Stevens RC; IJzerman AP; Heitman LH; Tebben A; Kufareva I; Handel TM Nature; 2016 Dec; 540(7633):458-461. PubMed ID: 27926736 [TBL] [Abstract][Full Text] [Related]
29. Synthesis and biological evaluation of 3-aminopyrrolidine derivatives as CC chemokine receptor 2 antagonists. Lim JW; Oh Y; Kim JH; Oak MH; Na Y; Lee JO; Lee SW; Cho H; Park WK; Choi G; Kang J Bioorg Med Chem Lett; 2010 Apr; 20(7):2099-102. PubMed ID: 20223662 [TBL] [Abstract][Full Text] [Related]
30. Conformational studies of 3-amino-1-alkyl-cyclopentane carboxamide CCR2 antagonists leading to new spirocyclic antagonists. Pasternak A; Goble SD; Doss GA; Tsou NN; Butora G; Vicario PP; Ayala JM; Struthers M; Demartino JA; Mills SG; Yang L Bioorg Med Chem Lett; 2008 Feb; 18(4):1374-7. PubMed ID: 18215519 [TBL] [Abstract][Full Text] [Related]
31. High level expression, activation, and antagonism of CC chemokine receptors CCR2 and CCR3 in Chinese hamster ovary cells. Parody TR; Stone MJ Cytokine; 2004 Jul; 27(1):38-46. PubMed ID: 15207250 [TBL] [Abstract][Full Text] [Related]
33. Six polycyclic pyrimidoazepine derivatives: syntheses, molecular structures and supramolecular assembly. Acosta Quintero LM; Palma A; Cobo J; Glidewell C Acta Crystallogr C Struct Chem; 2016 Apr; 72(Pt 4):346-57. PubMed ID: 27045186 [TBL] [Abstract][Full Text] [Related]
34. Synthesis, structure-activity relationship and in vivo antiinflammatory efficacy of substituted dipiperidines as CCR2 antagonists. Xia M; Hou C; DeMong DE; Pollack SR; Pan M; Brackley JA; Jain N; Gerchak C; Singer M; Malaviya R; Matheis M; Olini G; Cavender D; Wachter M J Med Chem; 2007 Nov; 50(23):5561-3. PubMed ID: 17929797 [TBL] [Abstract][Full Text] [Related]
35. [Synthesis and biological activity of pyrido(2,3-e)-1,4-diazepine and of pyrido(2,3-b)(1,4)diazepine]. Carboni S; Da Settimo A; Bertini D; Ferrarini PL; Livi O; Tonetti I Farmaco Sci; 1975 Apr; 30(4):238-47. PubMed ID: 1183603 [TBL] [Abstract][Full Text] [Related]
36. Discovery of 3,5-bis(trifluoromethyl)benzyl L-arylglycinamide based potent CCR2 antagonists. Yang L; Zhou C; Guo L; Morriello G; Butora G; Pasternak A; Parsons WH; Mills SG; MacCoss M; Vicario PP; Zweerink H; Ayala JM; Goyal S; Hanlon WA; Cascieri MA; Springer MS Bioorg Med Chem Lett; 2006 Jul; 16(14):3735-9. PubMed ID: 16698264 [TBL] [Abstract][Full Text] [Related]
37. Spiroindenes and spiroindanes as antagonists of CC chemokine receptor 2: WO 2009023754. Carter PH Expert Opin Ther Pat; 2010 Feb; 20(2):283-9. PubMed ID: 20100008 [TBL] [Abstract][Full Text] [Related]
38. Discovery of disubstituted cyclohexanes as a new class of CC chemokine receptor 2 antagonists. Cherney RJ; Mo R; Meyer DT; Nelson DJ; Lo YC; Yang G; Scherle PA; Mandlekar S; Wasserman ZR; Jezak H; Solomon KA; Tebben AJ; Carter PH; Decicco CP J Med Chem; 2008 Feb; 51(4):721-4. PubMed ID: 18232650 [TBL] [Abstract][Full Text] [Related]
39. Discovery and synthesis of 6,7,8,9-tetrahydro-5H-pyrimido-[4,5-d]azepines as novel TRPV1 antagonists. Hawryluk NA; Merit JE; Lebsack AD; Branstetter BJ; Hack MD; Swanson N; Ao H; Maher MP; Bhattacharya A; Wang Q; Freedman JM; Scott BP; Wickenden AD; Chaplan SR; Breitenbucher JG Bioorg Med Chem Lett; 2010 Dec; 20(23):7137-41. PubMed ID: 20947352 [TBL] [Abstract][Full Text] [Related]
40. Discovery of INCB10820/PF-4178903, a potent, selective, and orally bioavailable dual CCR2 and CCR5 antagonist. Zheng C; Cao G; Xia M; Feng H; Glenn J; Anand R; Zhang K; Huang T; Wang A; Kong L; Li M; Galya L; Hughes RO; Devraj R; Morton PA; Rogier DJ; Covington M; Baribaud F; Shin N; Scherle P; Diamond S; Yeleswaram S; Vaddi K; Newton R; Hollis G; Friedman S; Metcalf B; Xue CB Bioorg Med Chem Lett; 2011 Mar; 21(5):1442-6. PubMed ID: 21295478 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]